ANRis, Inc.
PrivateLast Round
VC Round
Jul 8, 2024
Total Funding Raised
$1.34M
Company Overview
ANRis, Inc. is a biotechnology company that develops siRNA-based nucleic acid medicines utilizing its proprietary SNPD-siRNA technology to provide precise, personalized treatments for cancer and genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ANRis, Inc. Comparables
Compare ANRis, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| City Therapeutics | 77% | |
| aceRNA Technologies Co., Ltd. | 75% | |
| CLOVERNA Inc. | 72% | |
ANRis, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 8, 2024 | ||||
| Seed | Nov 28, 2023 |
ANRis, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| QB Capital | VC Round |
| WASEDA University Ventures | Seed |
| NCB Venture Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 8, 2024
Raised capital from NCB Venture Capital and QB Capital.
- Nov 28, 2023
$1.34M round led by WASEDA University Ventures.
ANRis, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ANRis, Inc.'s valuation, stock price, and market status.